The role of peripheral amide groups as hydrogen-bonding directors in the tubular self-assembly of dinucleobase monomers by Vázquez González, Violeta et al.
The Role of Peripheral Amide Groups as Hydrogen-Bonding
Directors in the Tubular Self-Assembly of Dinucleobase
Monomers
Violeta Vázquez-González,[a] María J. Mayoral,[a, b] Fátima Aparicio,[a] Paula Martínez-Arjona,[a]
and David González-Rodríguez*[a, c]
Nanotubes are a fascinating kind of self-assembled structure
which have a wide interest and potential in supramolecular
chemistry. We demonstrated that nanotubes of defined
dimensions can be produced from dinucleobase monomers
through two decoupled hierarchical cooperative processes:
cyclotetramerization and supramolecular polymerization. Here
we analyze the role of peripheral amide groups, which can form
an array of hydrogen bonds along the tube axis, on this self-
assembly process. A combination of 1H NMR and CD spectro-
scopy techniques allowed us to analyze quantitatively the
thermodynamics of each of these two processes separately. We
found out that the presence of these amide directors is
essential to guide the polymerization event and that their
nature and number have a strong influence, not only on the
stabilization of the stacks of macrocycles, but also on the
supramolecular polymerization mechanism.
Chemists are increasingly motivated to design novel nano-
tubular systems, due to their wide diversity of functions,[1] their
nanometer-scale dimensions, and their high aspect ratio. In fact,
tube-forming proteins, such as tubulin or aquaporin, or viruses
like the tobacco mosaic virus, are seen as a truly amazing
category of self-assembled systems with biological functions.
Possible applications of such materials with nanospaces of
confined dimensions[2] involve molecular sieve technologies,[2b]
chemo- and size-selective encapsulation and storage, catalysis
and sensing,[2a] or biomedical applications, such as drug trans-
port and biological ion channel mimics.[2c–e]
Probably the most important aspects in the design of
nanotubes or nanotube networks are the modulation of their
dimensions (i. e., adjusting the inner pore, tuning nanotube
diameter), as well as ruling internal and external functionality.
In this context, self-assembled nanotubes and nanochannels
built from organic molecules arise as promising materials that
offer some distinct advantages with respect to carbon,
inorganic or polymeric[3] materials. These include low-cost
preparation under equilibrium conditions, synthetic versatility,
biocompatibility, as well as precise tailoring of structure and
function.[3–4] Inspired by natural systems, the idea is to program
molecules with the required chemical information so that they
spontaneously assemble into well-defined tubular structures via
a combination of non-covalent interactions and cooperative
effects.[5]
In this context, we recently reported on the self-assembly of
dinucleobase rod-like monomers like GC1 (Figure 1a), compris-
ing complementary G and C bases at the edges, into tubular
structures[6] in alkane solvents.[6a] Remarkably, this assembly
process occurred through two decoupled cooperative steps of
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Figure 1. (a) Structure of S-chiral GC0–GC2 molecules (see also Figure 2). (b)
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different hierarchy (Figure 1b): 1) a cyclotetramerization
process[7] controlled by Watson-Crick G :C pairing and enjoying
a high chelate cooperativity,[8] and 2) a supramolecular polymer-
ization in which the macrocycles orderly stack to generate the
final nanotubes through a nucleation-elongation mechanism.
The peripheral amide group placed at the C base in GC1
was suspected to play a key role along the polymerization
phase, stabilizing GC1 tubular stacks by formation, just like in
peptide β-sheets, of an array of H-bonds parallel to the tube’s
main axis, so we called them “parallel directors”. Here, we
analyze the influence of these groups on this self-assembly
process. We prepared three other related monomers (Figure 1a)
endowed with 0 (GC0) or 2 (GC2 and GC2*) peripheral amides
and studied their self-organization, focusing on both the
cyclotetramerization and the polymerization processes. We
reveal that these parallel directors are indeed crucial to trigger
polymerization, and that they greatly contribute to the
stabilization of the tubular assemblies.
Synthesis. Monomers GC0–GC2 are endowed with a p-
phenylene central block having lateral alkyl chains with S-chiral
centers, and thus only differ in the number of peripheral amide
groups placed at the C unit. Monomer GC2* is analogous to
GC2, but we moved the chiral center to the lateral chain at the
C base by installing a valine derivative. However, despite
showing a similar association behavior as GC2, evolving from a
cyclic tetramer structure to longitudinal aggregates of the
expected diameter (see below), the assemblies of GC2* turned
out to be inactive in CD, an essential technique used in these
studies, so we discarded this compound for subsequent
experimental comparisons. The synthesis and molecular charac-
terization of the cytosine precursors, as well as the novel
dinucleobase monomers GC0, GC2 and GC2* (Scheme 1), is
detailed in the Experimental Section, as well as in the
Supporting Information.
The synthesis of GC1 and the rest of nucleobase and central
block precursors can be found in our previous work.[6a] Cytosine
C0[9] was prepared from 5-iodocytosine by an alkylation reaction
with the benzylic wedge W0,[10] followed by installation of the
terminal acetylene via Sonogashira coupling with trimeth-
ylsilylacetylene (TMSA) and subsequent deprotection of the
trimethylsilyl (TMS) group in the presence of fluoride ions. On
the other hand, precursors C2 and C2* were prepared from the
amine-protected cytosine C2.1[9] by Boc-deprotection, and
subsequent condensation reaction with acids W2[11] or W2*,
respectively, whose preparation is further detailed at the S.I.
Then, monomers GC0, GC2 and GC2* were synthesized by two
consecutive Sonogashira cross-couplings between diiododeriva-
tives B[12] or B1[13] and, firstly, the 5-ethynylcytosines C0, C2 and
C2*, to yield the corresponding monocoupled products, and,
subsequently, the 8-ethynylguanine G,[9,14] to arrive to the final
monomers.
The cyclotetramerization process. As stated in the Intro-
duction, when these GC dinucleobase molecules are gradually
exposed to experimental conditions that favor their association
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by H-bonding, a cyclotetramerization process, guided by G :C
Watson-Crick pairing interactions, is triggered first without
actually observing oligo/polymerization through monomer
stacking. Such monomer (GC) - cyclotetramer (c(GC)4) equili-
brium was studied by a number of spectroscopic techniques.
From our experience[6a] and preliminary studies (Figure S1), a
solvent of intermediate polarity like THF is the best candidate
to study the cyclotetramerization process, which can be
principally done with 1H NMR, CD and emission spectroscopies.
Since all macrocycles are formed from similar complementary G
and C nucleobases, we expected that the association process of
all monomers during this first equilibrium would be compara-
ble, at least qualitatively.
Temperature- and concentration-dependent 1H-NMR experi-
ments in THF-d8 (Figures 2a–c and S2A, C) were first carried out
in order to calculate the molar fraction of c(GC)4 species in
diverse conditions and to evaluate the thermodynamic stability
of each cyclic tetramer. In all cases, the G-amide and C-amine
proton signals were detected at around 13.5 and 10.0 ppm (see
Figures S2A, C), which is typical for H-bonded G :C pairs. High
temperatures and low concentrations favor dissociation into GC
monomers while low temperatures and high concentrations
obviously promote c(GC)4 formation. It is interesting to remark
that, for all monomers, only these two species were detected in
slow exchange in the NMR timescale, and no sign of small open
oligomeric species was noticed, highlighting the strong all-or-
nothing cooperativity of the cyclotetramerization process. CD
experiments in the same conditions (Figures 2d–f and S2B, D)
were in agreement with the NMR results. As described in
previous work, CD spectroscopy turns out to be also very
informative to assess the formation of cyclic species along our
whole studies with dinucleoside monomers.[6a,8a,e] This kind of
molecules can switch between different conformations by
rotation around the σ-bonds in their rigid π-framework, that
dispose the nucleobase Watson-Crick edges either at the same
side or at opposite sides of the molecule. Upon cyclotetrameri-
zation, this degrees of freedom are lost and the Watson-Crick
faces at the edge nucleobases are blocked and forced to point
to the same side. Such conformational “locking” might enhance
the interaction between the chiral groups and the π-conjugated
backbone, so that the system becomes CD active. Hence, the
CD trends recorded upon cyclization can be used to detect and
analyze quantitatively the cyclotetramerization process in a
complementary way and in a lower concentration range,
because non-cyclic or non-associated species are CD-inactive.[8]
The fixation of the planar syn conformation upon cyclotetrame-
rization also explains the marked red-shifts observed in the
absorption and emission spectra (see Figure S1). So, in the same
experimental conditions, the cyclotetramerization trends moni-
tored by 1H NMR and CD as a function of temperature or
concentration closely overlap, as shown in Figures 2g and S2F.
Figure 2. (a–c) Chemical structure and aromatic region of the 1H NMR spectra in THF-d8 and (d–f) CD spectra in THF of compounds (a, d) GC0, (b, e) GC1, and
(c, f) GC2 as a function of the temperature. In all cases C=1.0 · 10  4 M. c(GC)4 and GC proton signals are marked with colored squares or rods, respectively. (g)
Representation of the molar fraction of molecules associated as c(GC)4 cycles (χT) calculated by
1H NMR (circles) or CD (triangles) as a function of the
temperature. (h) Possible conformations adopted by the amide substituents at the C base. In some of them an intramolecular H-bond may be formed leading
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However, each macrocycle displayed a markedly different
stability: c(GC2)4>c(GC0)4>c(GC1)4. For instance, at 298 K and
at an identical 10  4 M concentration in THF, the molar fraction
of molecules associated as cyclic tetramers (χT) was >0.9 for
GC2, 0.75 for GC0 and 0.55 for GC1. These χT values as a
function of concentration and temperature allowed us to
calculate the cyclotetramerization constant (KT) and, through
van’t Hoff plots (Figure S2G), the corresponding enthalpy (ΔH)
and entropy (ΔS) changes associated to the cyclotetrameriza-
tion equilibria, which are compared in Table 1a. The only
exception was GC2, for which, due to the strong association in
these conditions, only a lower KT limit could be determined.
In order to compare the cooperativity of each cyclotetrame-
rization process, the corresponding reference association con-
stants for each G :C nucleobase pair (KG :C)
[15] were measured in
separate titration experiments (see Figure 3 and S3 A), and the
effective molarity (EM) was calculated using the relationship
KT=EM ·KG :C
4. Thus the noted differences in cycle stability may
either come from a different EM for each cycle, from the subtle
differences in G :C association constants that the lateral
substituents at the C nucleobase may cause, or from a
contribution of both parameters. From the data shown in
Table 1a, it is clear that, even if there are not important
differences in KG :C, the fact that each cycle is bound by 4 G :C
interactions, and thereof KG :C is raised to the 4
th power in the
equation, can already explain the notable differences in cycle
stability. The calculated EM values are, on the other hand and
as expected, very similar for each cycle and in the order of
102 M, thus in the same range as those calculated for related
cycles made from G  C dinucleosides.[8a]
The polymerization process. We next investigated the
supramolecular polymerization to yield self-assembled nano-
tubes. This is a second stage in the overall self-assembly
landscape of these GC dinucleobase monomers that is only
triggered when the molecules are exposed to experimental
conditions that really increase their degree of aggregation, like
in highly apolar solvents. In such conditions, as was demon-
strated for GC1 in our previous work,[6a] and as will be proven
below for the rest of GC molecules studied in this work, the
cyclic tetramers are already formed quantitatively, meaning that
both processes (i. e., cyclotetramerization and supramolecular
polymerization) are totally decoupled. The number of peripheral
amides is expected to play an important role in this polymer-
ization process, since they should be involved in enhancing
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GC0 0.55 ·103 4.3 · 1013 4.7 · 102   143.4   215.1
GC1 0.41 ·103 3.4 · 1012 1.2 · 102   173.4   331.2
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[J ·mol  1 · K  1]
GC2 279 4.0 · 104 1   83�2   192�6
[a] Reference G :C association constant calculated in separate experiments (see Figures 3 and S3A). [b] Cyclotetramerization constant. [c] Effective molarity
calculated as: EM=KT/KG:C
4. [d] Cyclotetramerization enthalpy and [e] entropy. [f] Could not be determined. [g] Elongation temperature at 3.0 · 10  5 M.
[h] Nucleation and [i] elongation constants, [j] cooperativity factor, and elongation [k] enthalpy and [l] entropy of the polymerization process. [m] Melting
temperature calculated from the isodesmic model. [n] Calculated using the van't Hoff equation.
Figure 3. 1H NMR titration experiments of G (guest) over (a) C0, (b) C1, or (c) C2 (host) at a constant host concentration of 5 mM in THF-d8. The corresponding
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stacking interactions between the macrocycles, thus contribu-
ting to the stabilization of the resulting nanotubes. As also
shown in our previous work,[6a] both the cyclotetramerization
and polymerization processes can be monitored by CD,
absorption or emission spectroscopy. When analyzing and
comparing the trends taken from each technique, they perfectly
overlap at any concentration and provide virtually the same
thermodynamic data. However, CD is the technique that
provides a higher difference between cyclotetramer and
polymer spectroscopic features, both visually and for quantita-
tive analyses.
We first monitored the spectroscopic changes occurring
upon increasing the volume fraction of heptane (Vh) in mixtures
with THF, from Vh=0 to Vh=0.99, at different concentrations
(Figures 4a–c and S4A–C). As shown in Figure 4d, two processes
were observed for GC1 and GC2 upon increasing Vh: the
monomer-macrocycle equilibrium was monitored from Vh=0 to
ca. 0.4-0.5. At that point a CD spectrum that is virtually identical
for all molecules is obtained, with a strong negative signal and
a weak, positive Cotton effect with zero-crossing at ca. 439 nm.
Then, a plateau is reached up to Vh=0.7–0.8 in which this CD
spectrum remains invariable, meaning that the c(GC)4 tetramers
are the only species in solution. The supramolecular polymer-
ization of the tetramers was then activated at higher heptane
contents. This is experimentally observed by a drastic change in
the CD spectra, and the stacked tubular polymers now show a
strong bisignated signal with zero-crossing at ca. 428 nm.
Interestingly, the polymerization of c(GC2)4, with two peripheral
amides per monomer, took place at a significantly lower bad
solvent content (Vh=0.7) than the polymerization of c(GC1)4
(Vh=0.85), which is endowed with a single amide per monomer.
On the contrary, for GC0, devoid of these peripheral H-bonding
groups, only the cyclotetramerization process was recorded,
and this compound remained associated as c(GC0)4 cyclic
tetramers even in pure heptane. These findings indicated that
the presence and number of peripheral amides plays indeed a
key role in the formation of the polymeric nanotubes. At this
point, it is interesting to note that GC2* shows a polymerization
process somewhat less favourable than GC2, most likely as a
result of a higher steric hindrance caused by the isopropyl
Figure 4. (a–c) Changes observed in the CD spectra as a function of the volume fraction of heptane (Vh) in mixtures with THF for (a) GC0, (b) GC1, and (c) GC2
(C=3.0 · 10  5 M; T=298 K). Normalized CD changes at 429 nm as a function of (d) Vh for GC0-GC2 or (e) the temperature for GC1 and GC2. (αT= fraction of
cyclotetramers, αN= fraction of aggregated nanotubes). (f,g) TEM images of the assemblies formed by GC2 drop-casted from diluted solutions of high Va. (h)
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group around the amide director. Although we could not
record GC2*’s CD changes, we could compare the
supramolecular behaviour of this molecule with the one shown
by GC2 in denaturalization experiments by increasing the
volume fraction of THF in heptane at a constant temperature
and concentration, monitored by absorption spectroscopy (Fig-
ure S4F).
In order to have a deeper insight into the polymerization of
c(GC1)4 and c(GC2)4, we conducted temperature-dependent
measurements monitored by CD and absorption at different
concentrations and at a fixed solvent composition, which was
chosen in each case so as to cover as much of the polymer-
ization process as possible within the experimental temperature
range (Vh=0.97 for GC1 and Vh=0.81 for GC2; Figures 4e and
S4E). As expected, the polymerization process is dependent on
concentration and the elongation temperature decreases as the
sample is concentrated and with the number of peripheral
amides, indicating again a strongest association for GC2 than
for GC1. But surprisingly, the shape and the underlying analysis
of the cooling curves revealed drastically different polymer-
ization mechanisms. GC1 exhibited a cooperative polymer-
ization that was analyzed by a nucleation–elongation model,[16]
which allowed us to calculate the most important thermody-
namic parameters (see Tables 1b and S2),[6a] and revealed a
small cooperativity factor (σ). On the contrary, GC2 (and GC2*,
see Figure S4F) displayed sigmoidal features that were analyzed
by the isodesmic model, with σ=1.[17]
Although we do not have a clear explanation, we believe
this difference is more likely due to the nature of the peripheral
C substituents than to the fact that each cooling curve was
measured at a different Vh. As shown in Figure 2h, the pendant
groups at the C base can adopt different conformations. In
some of them the amide groups are bound to solvent
molecules and in some others intramolecular H-bonds can be
established.[18] We discard the formation of intermolecular H-
bonds between these amides at high THF contents, since their
chemical shifts do not change with concentration (Figure S2C).
A quite probable conformation for GC1 and GC2, where a 7-
membered H-bonded ring is formed intramolecularly, is
represented in Figure 2h as conformation II. However, upon
Watson-Crick pairing, such conformation must become much
less populated, because the C-carbonyl group needs to bind
the G base as well. Hence, cyclization would “release” such
amide group, which would be available for polymerization.
However, in GC2, a different kind of intermolecular H-bond
leading to a 6-membered ring can be expected (conformation
III), which might “sequester” the amide group and thus
influence the polymerization mechanism.
We made a number of experiments to try to get a deeper
insight into this issue without much success. On one hand, 1H
NMR spectra down to 178 K were acquired with the individual C
nucleobases (C1 and C2; see Figure S3B), to try to “freeze” one
of these conformations and detect it in slow exchange.
However, the compounds precipitated below 218 K and the
amide signals (and actually all protons involved in H-bonding
interactions) only showed a gradual downfield shift with
decreasing temperature (see also Figure S2A). On the other
hand, we recorded different 1H NMR spectra at gradually
increasing volume fractions of cyclohexane-d12 into THF-d8, with
the aim to see a change in the amide chemical shifts just when
polymerization is triggered. However, when c(GC1)4 and c(GC2)4
start to polymerize, their 1H NMR signals become too broad and
disappear before any H-bonding rearrangement can be de-
tected (Figure S2E). FT-IR spectroscopy experiments performed
in THF or THF:heptane (1 : 99) solutions or in the solid state (see
Section S0 at the Supporting Information) did not help in
providing further information either about the nature of the
most abundant conformation in each of these situations. We
analyzed both the amine/amide N  H region between 3000 and
3600 cm  1 and the carbonyl region between 1500 and
1800 cm  1. However, the high number of functional groups
present in each monomer makes this analysis extremely
difficult. For instance, a monomer like GC2 has 4 C=O groups, 2
exocyclic NH2 groups and 3 N  H amide groups. Besides,
depending on the conditions, some of these groups may be H-
bonded intramolecularly, intermolecularly, or some may be
bound to solvent molecules, while some other may not be H-
bonded. We tried to simplify the system by comparing first the
nucleobase fragments C0, C1, C2 and G, but even there, no final
conclusion could be obtained.
Finally, we drop-casted GC1, GC2 and GC2* samples from
diluted solutions with Vh >0.8, and analyzed them by TEM. As
Figures 4f-h and S5 demonstrate, longitudinal objects with a
measured diameter of 3.9�0.7 nm (GC1) or 4.0�0.8 nm (GC2),
which coincides with the hard aromatic section of the cyclic
tetramers, were imaged. We also noted that it is quite frequent
to observe aligned nanotube bundles, especially as the time in
solution before deposition becomes longer, which would be
the result of van der Waals interactions between the peripheral
alkyl chains of individual nanotubes. As a matter of fact, in
some cases, especially if the sample concentration is high, we
observed nanotube precipitation with time at the highest Vh
values. It is important to note that SAXS and DLS measure-
ments, as shown in our previous work for GC1,[6a] were in
agreement with the formation of large cylindrical aggregates
with a cylinder diameter of 4�1 nm and a core diameter of
about 1 nm.
In this work we focused on the analysis of the influence of
the nature of the directors placed at the C base on the
thermodynamics of the supramolecular processes to build self-
assembled nanotubes. We focused separately on the cyclo-
tetramerization and the supramolecular polymerization events.
We noted that these substituents lead to slight deviations in
the association constants between G and C nucleobases that
can however have a strong impact on macrocycle stability.
More importantly, the presence of these amide groups is
essential to trigger and guide the stacking of the c(GC)4
“supramonomers”, while their number greatly influences tube
stability. Unexpectedly, the supramolecular polymerization
mechanism is also modulated by these external groups,
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Experimental Section
General Methods: Mass Spectrometry (MS) and High Resolution-
Mass Spectrometry (HRMS) MALDI-TOF spectra were obtained from
a BRUKER ULTRAFLEX III instrument equipped with a nitrogen laser
operating at 337 nm. NMR spectra were recorded with a BRUKER
AVANCE-II 300 MHz or a BRUKER DRX 500 MHz instrument. The
temperature was actively controlled at 298 K. Chemical shifts are
measured in ppm using the signals of the deuterated solvent as the
internal standard [CDCl3 calibrated at 7.26 ppm (
1H) and 75.0 ppm
(13C), DMSO-d6 calibrated at 2.50 ppm (
1H) and 39.5 ppm (13C) and
THF-d8 calibrated at 3.58 (
1H) and 39.5 ppm (13C)]. Due to solubility
problems the 13C-NMR data for some final monomers and their
derivatives could not be performed. Column chromatography was
carried out on silica gel Merck-60 (230–400 mesh, 60 Å), and TLC on
aluminium sheets precoated with silica gel 60 F254 (Merck). FT-IR
spectra were recorded with a PerkinElmer spectrometer UATR two.
UV-Visible experiments were conducted using a JASCO V-660
apparatus. Emission spectra were recorded in a JASCO FP-8600
equipment using excitation and emission bandwidths of 5 nm in
both cases, and a 50 ms response. CD spectra were recorded with a
JASCO J-815 equipment. The slit width was set at 1000 μm and a
DIT of 2 s was used. In all these three instruments the temperature
was controlled using a JASCO Peltier thermostatted cell holder with
a range of 263–383 K, adjustable temperature slope, and accuracy
of �0.1 K. Transmission electron microscopy (TEM) images were
obtained with a JEOL-JEM 1010 instrument operating at 100 kV for
the stained samples and a JEM 1400K PLUS instrument operating at
100 kV for non-stained samples.
Standard procedures
Standard Procedure A for the nucleobase alkylation reaction. To a
suspension of the nucleobase starting material (1 eq) and a base
(1.2 q) (indicated in each case) in dry DMF (volume indicated in
each case) the corresponding iodoalkane or benzyl bromide/
chloride (1.2 eq) (indicated in each case) was added dropwise. The
mixture was stirred under argon at 40 °C for a period of time
(indicated in each case) until completion, which was monitored by
TLC. Work-up and purification methods are also indicated in each
case.
Standard Procedure B for the Sonogashira coupling with TMSA and
subsequent alkyne-TMS group deprotection. A dry THF/Et3N (4 :1)
solvent mixture was subjected to deoxygenation by three freeze-
pump-thaw cycles with argon. Then, this solvent was added to the
system containing the corresponding halogenated base (1 eq), CuI
(0.01 eq) and Pd(PPh3)2Cl2 (0.02 eq). The mixture was stirred at
room temperature for a few minutes. Then, trimethylsilylacetylene
(TMSA; 2 eq) was added dropwise. The reaction was stirred under
argon at a given temperature for a period of time (indicated in
each case) until completion, which was monitored by TLC. Then,
the mixture was filtrated over celite and the solvent evaporated
under vacuum. The resulting crude was placed in a round-bottom
flask equipped with a magnetic stirrer, followed by addition of THF
and the mixture was stirred at room temperature until the solid
was dissolved. Then, hydrated tetrabutylammonium fluoride
(TBAF ·3H2O; 1 eq) was slowly added at 0 °C. The mixture was
allowed to reach room temperature and it was stirred until its
completion, which was monitored by TLC (approximately 1 hour in
all cases). The solvent was evaporated at reduced pressure and the
product was purified by column chromatography (eluent indicated
in each case). The resulting solid was finally washed with cold
acetonitrile.
Standard Procedure C for the Sonogashira coupling with ethynyl-
nucleobases. A dry THF or THF/NEt3 solvent mixture (indicated in
each case) was subjected to deoxygenation by three freeze-pump-
thaw cycles with argon. Then, this solvent was added over the
system containing the corresponding ethynyl-substituted base
(quantity indicated in each case), iodoarene derivative (quantity
indicated in each case), Cul (0.01 eq) and PdCl2(PPh3)2 or Pd(Ph3)4
(0.02 eq). The mixture was stirred under argon at 40 °C (unless
indicated otherwise) until completion, which was monitored by
TLC. The purification methods are explained in each case.
Starting materials. Chemicals were purchased from commercial
suppliers and used without further purification. Solid hygroscopic
reagents were dried in a vacuum oven before use. Reaction
solvents were thoroughly dried before use using standard methods.
The synthesis and characterization of compounds W,[19] W0,[10]
W2,[11] C2.1,[9] C,[9] B,[12] B1,[13] G[9] and GC1[6a] have already been
described in the literature.
Synthetic procedures and characterization data of the
nucleobase substituents (W2*, Scheme S1)
W2.1*: To a solution of the acid W[19] (3.0 g, 4.5 mmol) in dry CH2Cl2
(50 mL) at 0 °C, EDC (1.7 g, 9.0 mmol) and HOBt (1.2 g, 9.0 mmol)
were added, and then the solution was stirred for ten minutes. In
another flask, a solution of the aminoacid (1.1 g, 6.7 mmol) and
Et3N (1.2 mL, 9.0 mmol) in CH2Cl2 (40 mL) was stirred for 15 minutes,
and then added to the solution of the acid. Once the addition was
completed the ice bath was removed, the resulting solution was
stirred at room temperature overnight. Once the reaction was
completed, the solution was diluted with CH2Cl2 and then washed
with HCl (0.1 N), NaHCO3 (sat) and NaCl (sat). The phases were
separated and the organic layer was dried with Na2SO4. Finally, the
solvent was evaporated under reduced pressure, and the resulting
product was purified by column chromatography using AcOEt/
Cyclohexane (1 :6) as eluent. The desired product was obtained as a
white solid (3.2 g, 90%). 1H-NMR (300 MHz, CDCl3) δ=6.99 (s, 2H,
H1), 6.52 (d, J=8.7 Hz, 1H, NH), 4.75 (dd, J=8.6, 5.0 Hz, 1H, CH2),
4.00 (q, J=6.8 Hz, 6H, OCH2), 3.77 (s, 3H, OCH3), 2.26 (td, J=6.9,
5.0 Hz, 1H, H3), 1.77 (ddd, J=21.3, 8.5, 6.3 Hz, 6H, OCH2CH2), 1.60–
1.27 (m, 54H, OCH2CH2(CH2)9CH3), 0.99 (t, J=6.8 Hz, 6H, CH3
4), 0.93–
0.81 (m, 9H, O(CH2)11CH3) ppm.
13C-NMR (75 MHz, CDCl3) δ=172.7,
167.0, 153.0, 141.5, 128.9, 105.9, 73.4, 69.3, 57.5, 52.0, 31.9, 31.5,
30.2, 29.7, 29.61, 29.57, 29.55, 29.50, 29.31, 29.28, 26.0, 22.6, 18.9,
18.0, 14.0 ppm. MS (ESI+): Calculated for C49H89NO6: 788.23; found:
789.69 [M+H]+. [α]D20= +11.78 (c=1, CHCl3).
W2*: To a suspension of the ester W2.1* (788.0 mg, 1.0 mmol) in
MeCN (40 mL) at room temperature, NaOH 2N (3.2 mL, 6.5 mmol)
was added, and the solution was then heated at 40 °C overnight.
Once the reaction was completed, the solvent was removed under
reduced pressure. The crude product was dissolved in CH2Cl2 and
the solution was acidified until pH 3 was reached. The solution was
then washed with NaCl and dried with Na2SO4. The evaporation of
the solvent led to the final product (735.3 mg, 95%). 1H-NMR
(300 MHz, CDCl3): δ=9.57 (s broad, 1H, OH), 6.99 (s, 2H, H
1), 6.62
(dd, J=8.6, 2.4 Hz, 1H, NH), 4.75 (dd, J=8.4, 4.8 Hz, 1H, H2), 3.99 (td,
J=6.5, 4.9 Hz, 6H, OCH2), 2.42–2.26 (m, 1H, H
3), 1.96–1.67 (m, 6H,
OCH2CH2), 1.46 (dd, J=10.2, 5.3 Hz, 6H, OCH2CH2CH2), 1.40–1.21 (m,
48H, OCH2CH2CH2 (CH2)8CH3), 1.03 (t, J=6.9 Hz, 6H, CH3
4), 0.97–0.79
(m, 9H, O(CH2)11CH3) ppm.
13C-NMR (75 MHz, CDCl3) δ=175.4, 167.6,
152.9, 141.5, 128.3, 105.8, 73.3, 69.2, 57.4, 31.6, 31.0, 30.0, 29.42,
29.40, 29.38, 29.36, 29.34, 29.3, 29.12, 29.08, 29.06, 25.81, 25.78,
22.4, 18.8, 17.7, 13.8 ppm. MS (ESI+): Calculated for C48H89NO6:
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Synthetic procedures and characterization data for the new
cytosine derivatives (C0, C2 and C2*, Schemes 1 and S2)
C0.1. Following Standard Procedure A, to a solution of C[9] (1.0 g,
4.2 mmol) in dry DMF (100 mL), a 1.0 M solution of Bu4NOH in
MeOH was added (4.2 mL, 4.2 mmol) and the mixture was stirred
for 30 minutes at 50 °C. Then, 1-(bromomethyl)-3,4,5-tris
(dodecyloxy)benzene (W0)[10] (3.4 g, 4.6 mmol) was dissolved in dry
DMF (50 mL) and added via cannula to the solution. This solution
was stirred for 12 h. After completion, the solvent was evaporated
under reduced pressure. The residue was purified by column
chromatography eluted with CHCl3:MeOH (20 :1) to afford C0.1 as a
white solid (2.8 g, 76%). 1H-NMR (300 MHz, CDCl3): δ=9.10 (s broad,
1H, C4NH-H), 7.48 (s, 1H, H6), 6.46 (s, 2H, s, H2), 5.65 (s, 1H, C4NH-H),
4.82 (s, 2H, N1CH2), 3.92 (t, J=6.3 Hz, 6H, OCH2), 1.75 (m, 6H,
OCH2CH2), 1.24 (m, 54H, OCH2CH2(CH2)9CH3), 0.86 (m, 9H, O-
(CH2)11CH3) ppm.
13C-NMR (75 MHz, CDCl3) δ=165.0, 155.1, 153.6,
148.3, 138.4, 130.6, 107.1, 90.2, 84.0, 77.3, 75.0, 73.4, 69.3, 52.7, 32.0,
30.4, 29.8, 29.7, 29.5, 26.17, 22.74, 14.2 ppm. HRMS (ESI+): Calcu-
lated for C47H83IN3O4: 880.5422 [M+H]
+. Found: 880.5454 [M+H]+.
m. p. 115.4–117.7 °C.
C0. Following Standard Procedure B, to a solution of C0.1 (500.0 mg,
0.6 mmol), Pd(Ph3)2)Cl2 (7.7 mg, 0.01 mmol), and CuI (1.1 mg,
0.01 mmol) in THF/Et3N (5 mL), TMSA (1.4 mL, 2.3 mmol) was added
and the mixture stirred at 40 °C overnight. Once the reaction was
completed, the solvent was evaporated, the resulting crude was
suspended in THF (10 mL) and TBAF ·3H2O (625.0 mg, 0.6 mmol)
was added. After completion the solvent was evaporated and the
resulting residue was purified by column chromatography eluted
with CHCl3:MeOH (50 :1), affording C0 as a pale solid (340.0 mg,
77%). 1H-NMR (300 MHz, CDCl3): δ=7.47 (s, 1H, H
6C), 6.87 (s broad,
1H, C4NH-H), 6.49 (s, 2H, H2), 5.67 (s broad, 1H, C4NH-H), 4.87 (s, 2H,
N1CH2), 3.93 (td, J=6.5, 2.2 Hz, 6H, OCH2), 3.32 (s, 1H, C�CH), 1.89–
1.52 (m, 6H, OCH2CH2), 1.28 (m, 54H, OCH2CH2(CH2)9CH3), 1.03–0.67
(m, 9H, O(CH2)11CH3) ppm.
13C-NMR (75 MHz, CDCl3): δ=165.0,
155.1, 153.6, 148.3, 138.4, 130.6, 107.1, 90.2, 84.0, 77.3, 75.0, 73.4,
69.3, 52.7, 32.0, 30.4, 29.8, 29.7, 29.5, 26.2, 22.7, 14.2 ppm. HRMS
(ESI+): Calculated for C49H84N3O4: 778.6456 [M+H]
+. Found:
778.6464 [M+H]+. m. p. 94.2–95.9 °C.
C2. To a suspension of C2.1[9] (270.0 mg, 1.0 mmol) in CH2Cl2
(26 mL), TFA (4.0 mL, 51.4 mmol) was added. The resulting solution
was stirred at room temperature for 3 h, then TFA was removed by
coevaporation with CH2Cl2 under reduced pressure. The resulting
crude was re-dissolved in dry DMF and stirred at room temperature
for 20 minutes, then cooled to 0 °C. Meanwhile, to a solution of the
acid W2[11] (710.0 mg, 1.0 mmol) in CH2Cl2 at 0 °C, EDC (267.2 mg,
1.9 mmol), HOBt (331.2 mg, 2.5 mmol) and DIPEA (0.3 mL,
1.9 mmol) were added. The solution was stirred at room temper-
ature for one hour, the solvent was removed under reduced
pressure and the crude re-dissolved with DMF and a few drops of a
CHCl3:MeOH (10 :1) mixture. This solution was added to the solution
at 0 °C of the deprotected amine, and then stirred at room
temperature overnight. Once the reaction was completed, the
solution was washed with HCl (0.1 M), NaHCO3 (sat) and NaCl (sat).
The phases were separated and the organic layer was dried with
MgSO4 and the solvent evaporated under reduced pressure. The
crude product was purified by column chromatography using a
10 :1 CHCl3:MeOH mixture as eluent, affording a white solid
(89.1 mg, 50%). 1H-NMR (300 MHz, CDCl3): δ=8.71 (s broad, 1H,
NH5), 7.81 (s broad,1H, NH3), 7.46 (s, 1H, H6C), 7.08 (s, 2H, H6), 4.21 (s
broad, 2H, CH2
4), 4.19–3.87 (m, 8H, OCH2, CH2
2), 3.59 (s broad, 2H,
CH2
1), 3.25 (s, 1H, C�CH), 1.79–1.67 (m, 6H, OCH2CH2), 1.45–1.13 (m,
54H, OCH2CH2(CH2)9CH3), 0.88–0.84 (m, 9H, O(CH2)11CH3) ppm.
13C-
NMR (75 MHz, CDCl3): δ=170.6, 168.1, 165.0, 155.6, 153.2, 150.5,
141.7, 128.7, 106.3, 90.0, 83.9, 75.3, 73.7, 69.6, 50.2, 43.8, 38.1, 32.1,
30.5, 29.91, 29.87, 29.85, 29.82, 29.75, 29.6, 29.54, 29.52, 26.29,
26.25, 22.9, 14.7. MS (ESI+): Calculated for C53H90N5O6 [M+H]
+ :
892.68; found: 892.66 [M+H].
C2*: To a suspension of C2.1 (250.0 mg, 0.9 mmol) in CH2Cl2
(15 mL), TFA was added (3.0 mL, 0.04 mmol), the resulting solution
was stirred at room temperature for 3.5 h. Then, TFA was removed
by coevaporation with CH2Cl2. The resulting solid was re-dissolved
in CH2Cl2 (25 mL), then Et3N (276.0 μL, 2.0 mmol) was added and
the solution was stirred for 15 minutes. In another flask to a
solution of the acid W2* (465.0 mg, 0.6 mmol) in dry CH2Cl2 (25 mL)
at 0 °C, HOBt (162.0 mg, 1.2 mmol) and EDC (230.0 mg, 1.2 mmol)
were added. The mixture was stirred for 15 minutes, then, the
solution of the deprotected amine was added. The mixture was
stirred at room temperature overnight. Once the reaction was
completed, the solution was diluted with CH2Cl2 and then washed
with HCl (0.1 N), NaHCO3 (sat) and NaCl (sat). The phases were
separated, and the organic layer was dried with Na2SO4 and then
the solvent was evaporated. The crude product was purified by
column chromatography, eluted with CHCl3: MeCN (30 :1) obtained
C2* as a white solid (404.0 mg, 48%). 1H-NMR (300 MHz, CDCl3) δ=
9.01 (m, 1H, N3H), 7.87 (s broad, 1H, NH-H), 7.27 (s, 1H, CH6), 7.05 (s,
2H, H6), 6.94 (d, J=9.3 Hz, 1H, N5H), 5.56 (broad, 1H, NH-H), 5.09 (dd,
J=6.9, 9.3 Hz, 1H, H4), 4.17–3.92 (m, 2H, CH2
2), 3.60–3.58 (m, 2H,
N1CH2) 4.02 (m, 6H, OCH2), 2.96 (s, 1H, C�CH), 2.15 (m, 1H, H
7), 1.88–
1.64 (m, 6H, OCH2CH2), 1.54–1.19 (m, 54H, OCH2CH2(CH2)9CH3), 1.04
(d, J=8.2 Hz, 3H, CH3
8), 1.02 (d, J=8.2 Hz, 3H, CH3
9), 0.89 (m, 9H, O
(CH2)11CH3) ppm.
13C-NMR (75 MHz, CDCl3) δ=172.8, 167.5, 164.9,
155.5, 153. 3, 150.5, 141.8, 129.3, 106.5, 89.8, 83.4, 77.3, 75.4, 73.8,
69.8, 58.7, 49.8, 37.20, 32.26, 32.08, 32.07, 30.5, 29.89, 29.85, 29.80,
29.74, 29.61, 29.59, 29.53, 29.51, 26.28, 26.25, 22.8, 19.5, 18.65,
14.24 ppm. MS (ESI+): Calculated for C56H95N5O6 [M+H]
+ : 934.40;
found: 935.75 [M+H]+. [α]D20=   1.21 (c=1, CHCl3).
Synthetic procedures and characterization data for the new
G  C final monomers (GC0, GC2 and GC2*, Schemes 1 and S3)
BC0: Following Standard Procedure C, B[12] (1.0 g, 1.56 mmol), C0
(403.0 mg, 0.51 mmol), Pd(Ph3)2Cl2 (6.8 mg, 0.01 mmol) and CuI
(0.9 mg, 0.005 mmol) were dissolved in a THF:Et3N mixture (15 mL).
the resulting mixture was stirred at 40 °C overnight. Once the
reaction was completed, the solvent was removed under reduced
pressure. The resulting product was purified by column chromatog-
raphy, using as eluent a CHCl3:MeOH 50 :1 mixture. The product
was obtained as a colorless oil (345 mg, 55%).1H-NMR (300 MHz,
CDCl3): δ =7.41 (s, 1H, H
6C), 7.28 (s, 1H, 1Hb), 6.85 (s, 1H, Ha), 6.78 (s
broad, 1H, NH-H), 6.49 (s, 2H, H2), 6.16 (bs, 1H, NH-H), 4.89 (s, 2H,
CH2
2), 4.04–3.89 (m, 10H, OCH2(CH2)10CH3, CH2
c), 1.95–1.69 (m, 10H,
OCH2CH2(CH2)9CH3, CH2
d), 1.67–1.52 (m, 2H, Hj), 1.46–1.08 (m, 70H,
OCH2CH2(CH2)9CH3, CH2
f,g,h, He,j), 1.01–0.76 (m, 27H, O(CH2)11CH3,
CH3
k,I,l). HRMS (ESI+): Calculated for C75H127IN3O6: 1292.8764 [M+H]
+.
Found: 1292.8772 [M+H]+.
BC2: Following Standard Procedure C, C2 (100.0 mg, 0.11 mmol),
B[12] (115.3 mg, 0.34 mmol), Pd(Ph3)2Cl2 (1.57 mg, 0.002 mmol) and
CuI (0.2 mg, 0.001 mmol) were dissolved in a THF:Et3N mixture. The
solution was stirred at 40 °C overnight. The solvent was then
removed under reduced pressure, and the resulting product was
purified by column chromatography, using as eluent a CHCl3:MeOH
100 :1 solvent mixture. The product was obtained as a colorless oil
(74.1 mg, 47%). 1H-NMR (300 MHz, CDCl3): δ=8.32 (s broad, 1H,
NH5), 7.44 (s, 1H, H6C), 7.09 (s, 1H, Hb), 7.10 (s, 1H, Ha), 7.06 (s, 2H, H6),
7.01 (s broad, 1H, NH-H), 6.75 (s, 1H, NH3), 6.25 (s broad, 1H, NH-H),
4.22 (qd, J=16.3, 5.7 Hz, 2H, CH2
4), 4.02–3.89 (m, 10H,
OCH2(CH2)10CH3, CH2
c, CH2
2), 3.76–3.60 (m, 4H, CH2
d), 1.80–1.67 (m,




(m, 66H, OCH2CH2(CH2)9CH3, CH2
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CH3
l,I,k). HRMS (MALDI+): Calculated for C79H132N5O8I: 1406.9193 [M
+H]+. Found: 1406.9187 [M+H]+.
B1C2*: Following Standard Procedure C for a Sonogashira coupling,
C2* (200.0 mg, 0.214 mmol), B1[13] (627.2 mg, 1.07 mmol), Pd-
(Ph3)2Cl2 (3.0 mg, 0.004 mmol) and CuI (0.4 mg, 0.0002 mmol) were
dissolven in a THF:Et3N mixture (10 mL). The resulting solution was
stirred at r.t. overnight, and then heated at 50 °C for 1 h. Once the
reaction was completed, the solvent was evaporated under reduced
pressure. The residue was then purified by column chromatogra-
phy, using as eluent a CHCl3:MeOH (100 :1) mixture. The product
was obtained as a white solid (140.0 mg, 47%). 1H-NMR (300 MHz,
CDCl3) δ=9.01 (m, 1H, N
3H), 7.87 (s broad, 1H, NH-H), 7.27 (s, 1H,
CH6), 7.20 (s, 1H, Hb), 7.05 (s, 2H, H6), 7.03 (s, 2H, Ha), 6.94 (d, J=
9.3 Hz, 1H, N5H), 5.56 (broad, 1H, NH-H), 5.09 (dd, J=6.9, 9.3 Hz, 1H,
H4), 4.17–3.92 (m, 2H, CH2
2), 3.60–3.58 (m, 2H, N1CH2) 4.02 (m, 10H,
OCH2), 2.15 (m, 1H, H
7), 1.88–1.64 (m, 10H, OCH2CH2), 1.54–1.19 (m,
74H, OCH2CH2(CH2)9CH3, OCH2CH2(CH2)5CH3), 1.04 (d, J=8.2 Hz, 3H,
CH3
8), 1.02 (d, J=8.2 Hz, 3H, CH3
9), 0.89 (m, 15H, O(CH2)11CH3,
O(CH2)7CH3) ppm.
GC0: Following Standard Procedure C for a Sonogashira coupling,
BC0 (100.0 mg, 0.082 mmol), G[9] (80.0 mg, 0.097 mmol), Pd(Ph3)4
(2.226 mg, 0.002 mmol) and CuI (0.2 mg, 0.001 mmol) were dis-
solved in a THF:Et3N mixture (3 mL). The mixture was stirred at
40 °C for 12 h. Once the reaction was completed, the solvent was
evaporated under reduced pressure. The crude product was
purified by column chromatography, using as eluent a CHCl3:MeOH
100 :1 mixture. The product was obtained as a yellow solid
(48.9 mg, 30%). 1H-NMR (300 MHz, CDCl3): δ=7.64 (s, 1H, NH-H),
7.41 (s, 1H, H6C), 7.13 (s, 1H, Hb), 7.01 (s, 1H, Ha), 6.79 (s, 2H, H2’), 6.53
(s, 2H, H2), 5.38 (s, 3H, CH2
1’), 4.94 (s, 2H, CH2
1), 4.21–3.82 (m, 20H,
OCH2(CH2)10CH3, CH2
c,d), 1.94–1.01 (m, 136H, OCH2(CH2)10CH3), CH2
,f,g,h,
He, Hj), 1.01–0.75 (m, 36H, O(CH2)11CH3, CH3
i,k,l). HRMS (MALDI+):
Calculated for C127H211N9O11Na: 2062.6153 [M+Na]
+. Found:
2062.6219 [M+Na]+.
GC2: Following Standard Procedure C for a Sonogashira coupling
BC2 (100.0 mg, 0.071 mmol), G[9] (70.0 mg, 0.085 mmol), Pd(Ph3)4
(1.15 mg, 0.001 mmol) and CuI (0.1 mg, 0.0007 mmol) were dis-
solved in a THF:Et3N mixture (3 mL) and stirred at 40°C overnight.
Once the reaction was completed, the solvent was removed under
reduced pressure. The residue was then purified by column
chromatography, using as eluent a CHCl3:MeOH 100 :1 mixture. The
product was obtained as a yellow solid (100.5 mg, 67%). 1H-NMR
(300 MHz, CDCl3): δ=7.98 (s broad, 1H NH
5), 7.75 (s broad, 1H, NH3),
7.51 (s, 1H, H6C), 7.13 (s, 1H, Hb), 7.03 (s, 1H, Ha), 6.99 (s, 2H, H6), 6.80
(s, 2H, H2’), 5.39 (s, 2H, CH2
1’), 4.34–3.94 (m, 20H, OCH2(CH2)10CH3,
CH2
c,d), 3.89–3.70 (m, 6H, CH2
4,2,1), 1.74–1.50 (m, 12H, CH2
,f,g,h), 1.49–
0.96 (m, 112 H, OCH2CH2(CH2)9CH3, H
e, Hj), 0.87 (m, 36H, O(CH2)11CH3,
CH3
i,k,l) ppm. HRMS (ESI+): Calculated for C129H215N10O12: 2097.6548
[M+H]+. Found: 2097.6566 [M+H]+.
GC2*: Following Standard Procedure C for a Sonogashira coupling,
B1C2* (101.7 mg, 0.071 mmol, G[9] (72 mg, 0.087 mmol), Pd(Ph3)4
(1.15 mg, 0.001 mmol) and CuI (0.13 mg, 0.0007 mmol) in THF. Then
a few drops of iPr2NH were added, and the solution was stirred at
r.t. overnight. Once the reaction was completed, the mixture was
filtered over a celite plug and washed with CHCl3:MeOH 10 :1. The
solvent was then evaporated under reduced pressure and the
residue was purified by column chromatography, using as eluent
CHCl3:MeOH 50 :1. The product was obtained as a yellow solid
(16 mg, 10%). 1H-NMR (300 MHz, CDCl3, TFA 1%) δ=7.96 (s, 1H,
H6C), 7.54 (s, 1H, Hb), 7.12 (s, 1H, Ha), 7.04 (s, 2H, H6), 7.00 (s broad,
1H, NH3), 6.80 (s, 2H, H2’), 5.40 (s, 2H, CH2
1’), 4.23–3.93 (m, 17H,
OCH2(CH2)10CH3, H
4, OCH2(CH2)6CH3), 3.90–3.71 (m, 4H, CH2
2, CH2
1),
1.85–1.72 (m, 16H, OCH2CH2(CH2)9CH3, OCH2CH2(CH2)5CH3), 1.51–
1.00 (m, 129H, OCH2CH2(CH2)9CH3, OCH2CH2(CH2)5CH3, H
7), 1.11–0.73
(m, 30H, O(CH2)11CH3, O(CH2)7CH3, CH3
8, CH3
9) ppm. HRMS (ESI+):
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